Inspection Readiness

Secure Your Regulatory Inspection Success

On average a new product takes approximately 10-15 years to develop, whether it is a biologic, a pharmaceutical product, a medical device, or a combination thereof.

• Can you risk the time and resources you invested in development by ignoring the importance of Inspection Readiness for a new product?
• Can you risk having an existing product off the market for remediation activities following a For Cause Inspection?
• Can your patients?

Radiofilum Pharmaceutical's expertise covers all aspects of Inspections. Inspection Readiness Evaluation, Project Management, your Inspection Program/Process, Logistics, and Training – are just some of the most important areas of Inspection Readiness. Our expertise can become your greatest asset. We are eager to become your partner in navigating this critical process.

PAI Readiness

Pre-approval Inspections are one of the most critical inspections any Biologic, Pharmaceutical or Medical Device firm will undertake. Failure to meet FDA expectations can have a huge impact on organizations, including:

• Delays to product launch.
• Thousands, if not millions of dollars, in remediation costs.
• Lost market share.
• Loss of a firm's credibility.

PAI readiness is critical, and Radiofilum Pharmaceutical is an industry leader in providing PAI Readiness to our clients.

BIMO Readiness

BIMO inspection readiness is essential for sponsors to ensure compliance with FDA regulations, protect data integrity, and uphold patient safety standards. By preparing thoroughly, sponsors:

• Ensure compliance with FDA regulations.
• Protect data integrity.
• Uphold patient safety standards.
• Help avoid costly delays.
• Prevent potential compliance issues.
• Facilitate smoother FDA inspections.